Table 1

Patient characteristics
Rheumatoid arthritis patients Healthy controls
Number 48 33
Age 56 ± 13 43 ± 13
% female 75 43
Disease duration (years) 12 ± 10
Cyclic citrullinated peptide IgG (units) 232 ± 397
Rheumatoid factor (IU/ml) 133 ± 236
C-reactive protein (mg/dl) 1 ± 1.75
Disease activity score 3.1 ± 1.5
DMARDs (%) 92%
TNFα inhibitors (%) 54%
Prednisone (%) 23%

DMARD, disease-modifying anti-rheumatic drug; TNF, tumor necrosis factor.

Bishu et al.

Bishu et al. Arthritis Research & Therapy 2014 16:R50   doi:10.1186/ar4480

Open Data